Xi Tang
- Cancer Research top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 2
- Pharmacology top 5%
- Biochemistry top 10%
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 3
- Gastric Cancer Management and Outcomes 3
-
- Cancer, Stress, Anesthesia, and Immune Response 3
- Co-authors
- Frank A. SinicropeElizabeth HalfKarin GwynAyşegül A. ŞahinYunjie SunM. Tien KuoIgnacio I. WistubaAnne S. Tsao
- Cited by
- Cancer ResearchOncologyPharmacology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xi Tang
34 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 365
- Oncology 553
- Pharmacology 338
- Biochemistry 66
- Pulmonary and Respiratory Medicine 330
Countries citing papers authored by Xi Tang
This map shows the geographic impact of Xi Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Tang more than expected).
Fields of papers citing papers by Xi Tang
This network shows the impact of papers produced by Xi Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Tang. The network helps show where Xi Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xi Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 29 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 8 | |
| 11 | 2018 | 29 | |
| 12 | 2017 | 4 | |
| 13 | 2015 | 39 | |
| 14 | 2014 | 20 | |
| 15 | 2013 | 41 | |
| 16 | 2012 | 235 | |
| 17 | 2012 | 15 | |
| 18 | 2006 | 97 | |
| 19 | [HER2 expression and its prognostic implication in lymph node negative breast carcinoma: a Meta-analysis]. | 2005 | 5 |
| 20 | Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. | 2002 | 288 |
About Xi Tang
Xi Tang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Research Studies (4 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (365 citations), Oncology (553 citations) and Pharmacology (338 citations). Xi Tang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Frank A. Sinicrope, Elizabeth Half, Karin Gwyn, Ayşegül A. Şahin, Yunjie Sun, M. Tien Kuo, Ignacio I. Wistuba, Anne S. Tsao, Hai T. Tran and Robert Lemos. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.